NCT07530588 Decentralized Imaging by REmote Computer Tomography for Cerebral Infarct Thrombolysis
| NCT ID | NCT07530588 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital of North Norway |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 52 participants |
| Start Date | 2025-07-17 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 52 participants in total. It began in 2025-07-17 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The DIRECT-CT trial is designed to test the hypothesis that remote controlled CT scanning combined with real time audio-and video conference (AVC) guided assessment from an experienced hospital stroke team (tele-stroke) at decentralized medical centers (DMC) reduces time to intravenous thrombolytic treatment compared to the standard pathway.
Eligibility Criteria
Inclusion Criteria: \- Patients in the catchments areas of the intervention and control group presenting with a clinical suspected diagnosis of stroke within symptom onset within the last 24 hours Exclusion Criteria: \- Patients presenting with a clinical suspected diagnosis of stroke more than 24 hours after symptom onset
Contact & Investigator
Tor Ingebrigtsen, MD, PhD
STUDY DIRECTOR
University Hospital of North Norway
Frequently Asked Questions
Who can join the NCT07530588 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07530588 currently recruiting?
Yes, NCT07530588 is actively recruiting participants. Contact the research team at agnethe.eltoft@unn.no for enrollment information.
Where is the NCT07530588 trial being conducted?
This trial is being conducted at Sandnessjøen, Norway, Tromsø, Norway.
Who is sponsoring the NCT07530588 clinical trial?
NCT07530588 is sponsored by University Hospital of North Norway. The principal investigator is Tor Ingebrigtsen, MD, PhD at University Hospital of North Norway. The trial plans to enroll 52 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.